FY2027 EPS Estimates for Aspen Aerogels Lowered by B. Riley

Aspen Aerogels, Inc. (NYSE:ASPN) – Stock analysts at B. Riley lowered their FY2027 earnings per share (EPS) estimates for Aspen Aerogels in a research note issued to investors on Tuesday, November 5th. B. Riley analyst R. Pfingst now anticipates that the construction company will post earnings per share of $1.64 for the year, down from their prior estimate of $1.79. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.10 per share.

Aspen Aerogels (NYSE:ASPN) last released its earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.16. The company had revenue of $117.80 million for the quarter, compared to analysts’ expectations of $101.99 million. Aspen Aerogels had a return on equity of 0.74% and a net margin of 0.39%. The business’s revenue for the quarter was up 144.4% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.22) EPS.

A number of other research analysts also recently weighed in on ASPN. Roth Mkm reissued a “buy” rating and set a $36.00 target price on shares of Aspen Aerogels in a research report on Wednesday, August 21st. Benchmark reissued a “buy” rating and set a $14.00 price objective on shares of Aspen Aerogels in a report on Thursday, August 8th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a research note on Thursday, October 31st. Piper Sandler cut their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Finally, Barclays assumed coverage on Aspen Aerogels in a research note on Tuesday, August 6th. They issued an “overweight” rating and a $27.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Aspen Aerogels has a consensus rating of “Moderate Buy” and a consensus target price of $29.40.

Aspen Aerogels Stock Performance

NYSE ASPN opened at $16.78 on Wednesday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.82 and a current ratio of 3.46. Aspen Aerogels has a 52-week low of $8.76 and a 52-week high of $33.15. The company has a 50-day simple moving average of $23.35 and a 200 day simple moving average of $24.61.

Hedge Funds Weigh In On Aspen Aerogels

A number of hedge funds and other institutional investors have recently bought and sold shares of ASPN. Point72 Hong Kong Ltd bought a new position in Aspen Aerogels in the second quarter valued at $84,000. nVerses Capital LLC purchased a new position in shares of Aspen Aerogels during the 2nd quarter valued at about $95,000. Quent Capital LLC purchased a new position in shares of Aspen Aerogels during the 3rd quarter valued at about $118,000. Point72 DIFC Ltd bought a new stake in Aspen Aerogels in the 2nd quarter worth approximately $121,000. Finally, Public Employees Retirement Association of Colorado purchased a new stake in Aspen Aerogels in the second quarter worth approximately $145,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Insider Activity at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at $14,523,709.20. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CEO Donald R. Young sold 63,355 shares of the business’s stock in a transaction dated Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now directly owns 483,640 shares in the company, valued at $14,523,709.20. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.30% of the stock is owned by corporate insiders.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.